Companies formed

Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.

Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.

The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

Software development for a novel biomarker to detect coronary heart disease.

Incorporated in July 2018

Origin: Oxford University, Radcliffe department of medicine

Contact: James Groves

Advanced materials and technologies in safe, lightweight, high performance hydrogen storage technology.

Incorporated in January 2011

Origin: Oxford University, Science and Technology Facilities Council

Circadian Therapeutics identify and bring to market pharmaceutical and diagnostic platforms for the effective management of physiological and pathological conditions through their ability to modify the body's circadian rhythms.

Incorporated in September 2016

Origin: Oxford University, Ophthalmology

ClinOx offers clients knowledge and expertise in the development, placement, conduct and analysis of early phase oncology clinical trials, with particular emphasis on pharmacokinetic and mechanistic endpoints.

Incorporated in June 2007

Origin: Oxford University, Nuffield Division of Clinical and Laboratory Sciences

Using leading edge human biomimetic platforms to test and develop therapeutics for serious human diseases.

Incorporated in July 2009

Origin: Oxford University, Institute of Biomedical Engineering

Cocotec builds software tools, which harness the power of automated formal verification. Its product, the Coco Platform, comes with a powerful software development environment that enables developers to build their software, automatically verify whether it is correct, and then generate high quality reliable code.

Incorporated in November 2018

Origin: Oxford University, Department of Computer Science

Crysalin develop a protein lattice technology that is founded on a novel form of highly ordered materials, crysalins, that are produced through modification of naturally occurring protein building blocks.

Incorporated in June 2007

Origin: Oxford University, Department of Biochemistry

Cytox develops a technology platform for tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias.

Incorporated in October 2006

Origin: Oxford University, Division of Clinical Neurology/Weatherall Institute of Molecular Medicine

Research and experimental development on biotechnology.

Incorporated in July 2020

Origin: Oxford University, Oncology

Parallel hardware/software design.

Incorporated in June 1999

Origin: Oxford University, Maths

DeepReason.ai offers a Knowledge Graph Management System that can integrate seamlessly with various enterprise, and public, data sources to perform fast and intelligent reasoning

Incorporated in January 2018

Origin: Oxford University, Computer Science

Contact: Adrian Coles

Deontics is software which guides doctors and patients through the scientific and clinical decision making.

Incorporated in August 2014

Origin: Oxford University, Department of Engineering Science

Designer Carbon Materials, Developing advanced nanomaterials for a range of applications, including energy harvesting, bio-sensing and quantum nanoelectronics.

Incorporated in April 2014

Origin: Oxford University, Department of Materials

Ready to get in touch?

Contact Us
© Oxford University Innovation